Standard

Phosphatidylethanolamine(34:2)_[M+H]1+ levels

ALDH1A2 · rs7165301

Stands on its own. Nothing else here links to this position yet — but the page above is the point: what the research found, what each genotype means, and where it came from, in language you can read. Links to conditions, drugs and the senses appear automatically if we write them.

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10⁻¹⁰, with 3 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10⁻⁵⁰. 2: ClinVar from one lab (1 star), or p ≤ 10⁻²⁰. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10⁻⁸). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 5,662 Pakistani ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.0563 higher (95% confidence interval 0.039-0.074); p = 2 × 10⁻¹⁰.

Where it sits Chromosome 15, band 15q21.3 — in a regulatory region of ALDH1A2.

What each result means

C/C No copy of the version the research linked to Phosphatidylethanolamine(34:2)_[M+H]1+ levels. This is the starting point the study compared everyone against.

C/T One copy of the version the research linked to Phosphatidylethanolamine(34:2)_[M+H]1+ levels. That is a smaller link than two copies.

T/T Two copies of the version the research linked to Phosphatidylethanolamine(34:2)_[M+H]1+ levels. That is the strongest link of the three results. A link in a study is not a diagnosis.

Source

Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci

Harshfield EL, Fauman EB, Stacey D, Paul DS, Ziemek D, Ong RMY, Danesh J, Butterworth AS, Rasheed A, Sattar T, Zameer-Ul-Asar, Saleem I

and 18 more — show all

Hina Z, Ishtiaq U, Qamar N, Mallick NH, Yaqub Z, Saghir T, Rizvi SNH, Memon A, Ishaq M, Rasheed SZ, Memon FU, Jalal A, Abbas S, Frossard P, Saleheen D, Wood AM, Griffin JL, Koulman A

BMC medicine · 2021 · PMID 34503513 · open access

Questions about rs7165301

What is rs7165301?

rs7165301 is a single position in the genome, in or near the ALDH1A2 gene. Published research associates it with phosphatidylethanolamine(34:2)_[m+h]1+ levels. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs7165301 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs7165301 come from?

GWAS Catalog, BMC medicine 2021, PMID:34503513. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Phosphatidylethanolamine(34:2)_[M+H]1+ levels (rs7165301). MyGeneLog™. https://www.mygenelog.com/variants/rs7165301

← See all variants